LUNG TYPICAL CARCINOID TUMOR

Clinical trials for LUNG TYPICAL CARCINOID TUMOR explained in plain language.

Never miss a new study

Get alerted when new LUNG TYPICAL CARCINOID TUMOR trials appear

Sign up with your email to follow new studies for LUNG TYPICAL CARCINOID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Early trial tests vaccine to turn immune system against rare cancers

Disease control Completed

This early-stage study tested the safety of an experimental cancer vaccine called SurVaxM in 19 patients with advanced neuroendocrine tumors that had spread. The vaccine aims to teach the body's immune system to recognize and attack cancer cells by targeting a specific protein th…

Matched conditions: LUNG TYPICAL CARCINOID TUMOR

Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

LUNG TYPICAL CARCINOID TUMOR

Get alerted when new LUNG TYPICAL CARCINOID TUMOR trials appear

Early trial tests vaccine to turn immune system against rare cancers